Mycophenylate mofetil: what role in the treatment of lupus? - Wikidata - wikimedia - TriplyDB

Mycophenylate mofetil: what role in the treatment of lupus?

Mycophenylate mofetil: what role in the treatment of lupus?

http://www.wikidata.org/entity/Q36458168

about

ANCA-associated vasculitis: new options beyond steroids and cytotoxic drugs.Mycophenolate mofetil in lupus glomerulonephritis: effectiveness and tolerability.

P2860

Q36802625-07028EE3-1312-43ED-A993-9645316F312D Q46970290-8963E9D5-EB18-4279-A5FE-9E9E210FCF22

P2860

Mycophenylate mofetil: what role in the treatment of lupus?

http://www.wikidata.org/entity/Q36458168

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Mycophenylate mofetil: what role in the treatment of lupus?

@ast

Mycophenylate mofetil: what role in the treatment of lupus?

@en

type

label

Mycophenylate mofetil: what role in the treatment of lupus?

@ast

Mycophenylate mofetil: what role in the treatment of lupus?

@en

prefLabel

Mycophenylate mofetil: what role in the treatment of lupus?

@ast

Mycophenylate mofetil: what role in the treatment of lupus?

@en

P1433

Q36458168-04FD18CA-30FB-491D-B9C6-22EAC796326A

P1476

Q36458168-13E193B5-08C2-4AD3-8898-68F23D2FC71B

P2093

Q36458168-5D97BCC6-84F3-40B9-97C6-5FE0B984C83E

P2860

Q36458168-0C303E52-6BFB-41DD-85EC-844DDD044006

Q36458168-1DB77785-11EA-4D35-9741-FA65DF472379

Q36458168-2D719BB0-CDBA-4CD5-9211-50A2D03F9912

Q36458168-2F443FCC-2AFF-4D46-AFD6-B3EA40C590D0

Q36458168-300F48F4-53FD-4E15-8F39-ED73A4613E70

Q36458168-487A1D2F-72D9-49D3-BCE6-2F5D1097B15A

Q36458168-4DCDD9CC-3F29-49BD-B397-9E8B05A70DDE

Q36458168-4DE9A4A1-1B22-4DCF-8CD1-5247086BB236

Q36458168-5AD9A0B2-03E8-4352-BE55-DE19DFF7692E

Q36458168-6171AE6D-DCA6-4D1C-A274-7F69D8727642

P304

Q36458168-DA7950B9-D4AC-49DF-96F1-B567EDF6CA81

P31

Q36458168-67C461D5-4B92-4A58-8747-49131D143586

Q36458168-71871cdc-0c49-455a-9e52-02d287100f06

P356

Q36458168-D4263A71-9A2B-43B4-A2C4-27D3F03E092E

P433

Q36458168-304C78C9-9C46-4377-BCAE-75159EA3078D

P478

Q36458168-1DFF4857-186E-4EE9-B7FF-A44DB24E8C0A

P577

Q36458168-15029293-343C-4B3D-840C-15338124AD12

P698

Q36458168-73CAD6C0-A167-4253-800B-F3BFCB64E515

P356

0961203306LU2294RR

P1433

P1476

Mycophenylate mofetil: what role in the treatment of lupus?

@en

P2093

M A Dooley

http://www.w3.org/2001/XMLSchema#string

P2860

Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States.

Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil.

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk.

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.

Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.

Outcome of chilean patients with lupus nephritis and response to intravenous cyclophosphamide.

Progression of lupus nephritis during treatment with mycophenolate mofetil.

Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil.

The safety and efficacy of MMF in lupus nephritis: a pilot study.

P304

179-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1191/0961203306LU2294RR

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16634373

http://www.w3.org/2001/XMLSchema#string